Aligos Amends ESPP to Increase Share Availability
Aligos Therapeutics amended its 2020 Employee Stock Purchase Plan to increase the maximum share issuance to 694,714 shares. This action requires stockholder approval and is intended to support the company's equitable compensation programs.
View filing at SEC.gov →